Efficacy of denosumab on bone mineral density in postmenopausal women with low bone mass and patients with breast cancer on adjuvant aromatase inhibitor (AI) therapy

被引：0
|
作者：
Bone, H. G. [1 ]
Ellis, G. [2 ]
Yuen, C. K. [3 ]
Kendler, D. L. [4 ]
Fan, M. [5 ]
Wang, H. [5 ]
Kim, D. [5 ]
Liu, Y. [5 ]
Dansey, R. [5 ]
Martin, J. San [5 ]
机构：
[1] Michigan Bone & Mineral Clin, Detroit, MI USA
[2] Seattle Canc Care Alliance, Seattle, WA USA
[3] Univ Manitoba, Winnipeg, MB, Canada
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
CALCIFIED TISSUE INTERNATIONAL | 2008年 / 82卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [1] Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer
    Sakaguchi, Koichi
    Ono, Hisako
    Nakatsukasa, Katsuhiko
    Ishikawa, Takashi
    Hasegawa, Yoshie
    Takahashi, Masato
    Niikura, Naoki
    Koizumi, Kei
    Sakurai, Teruhisa
    Shigematsu, Hideo
    Takahashi, Shunji
    Taira, Shinichiro
    Suzuki, Masato
    Narui, Kazutaka
    Miura, Daishu
    Yamada, Kimito
    Yoshimura, Mana
    Shioya, Hisashi
    Konishi, Eiichi
    Isao, Yokota
    Imai, Kojiro
    Fujikawa, Kei
    Taguchi, Tetsuya
    MEDICINE, 2019, 98 (32)
  • [2] Denosumab in postmenopausal women with low bone mineral density
    McClung, MR
    Lewiecki, EM
    Cohen, SB
    Bolognese, MA
    Woodson, GC
    Moffett, AH
    Peacock, M
    Miller, PD
    Lederman, SN
    Chesnut, CH
    Lain, D
    Kivitz, AJ
    Holloway, DL
    Zhang, C
    Peterson, MC
    Bekker, PJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (08): : 821 - 831
  • [3] Denosumab in postmenopausal women with low bone mineral density
    Schwartzman, Julie
    Yazici, Yusuf
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (22): : 2390 - 2390
  • [4] Denosumab in postmenopausal women with low bone mineral density
    Charles L. Loprinzi
    Current Oncology Reports, 2006, 8 (4) : 267 - 268
  • [5] Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
    Chen, Yi
    Zhu, Jun
    Zhou, Yiqin
    Peng, Jinhui
    Wang, Bo
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Marilyn L. Kwan
    Song Yao
    Cecile A. Laurent
    Janise M. Roh
    Charles P. Quesenberry
    Lawrence H. Kushi
    Joan C. Lo
    Breast Cancer Research and Treatment, 2018, 168 : 523 - 530
  • [7] Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy
    Kwan, Marilyn L.
    Yao, Song
    Laurent, Cecile A.
    Roh, Janise M.
    Quesenberry, Charles P., Jr.
    Kushi, Lawrence H.
    Lo, Joan C.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 168 (02) : 523 - 530
  • [8] Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer
    Villa, Paola
    Lassandro, Anna P.
    Amar, Inbal D.
    Vacca, Lorenzo
    Moruzzi, Maria C.
    Ferrandina, Gabriella
    Terribile, Daniela
    Masetti, Riccardo
    Scambia, Giovanni
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (01): : 33 - 39
  • [9] EFFICACY OF DENOSUMAB ON BONE MINERAL DENSITY IN PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS
    Tsagareli, M.
    Giorgadze, E.
    Dolidze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S252 - S252
  • [10] Bone health in postmenopausal women (PMW) with hormone-sensitive breast cancer (HSBC) receiving adjuvant aromatase inhibitor (AI) therapy
    Kalder, M.
    Hadji, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345